Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Somatus, founded in 2016 and headquartered in McLean, Virginia, is a leading provider of value-based kidney care services. The company focuses on integrated care for patients with or at risk of developing kidney disease, utilizing advanced technology and clinical services to improve patient outcomes and reduce healthcare costs. Somatus partners with health plans, health systems, and medical groups to deliver comprehensive care solutions.
Since its inception, Somatus has demonstrated significant growth and attracted substantial investor interest. The company has successfully raised $465 million in total funding across multiple rounds, with its most recent Series E round in February 2022 securing $325 million. This latest funding round valued Somatus at $2.5 billion, highlighting the company's strong market position and potential for future growth.
Somatus operates in the rapidly evolving healthcare sector, specifically in the home healthcare and medical facilities & services industries. The company's innovative approach to kidney care and its partnerships with major healthcare providers have positioned it as a key player in this space. Competitors in the field include Carenostics, Cricket Health, DaVita, Monogram Health, and Strive Health.
While there is currently no official information available regarding Somatus' IPO prospects, the company's substantial funding rounds and impressive valuation suggest it may be well-positioned for future growth opportunities. However, it's important to note that any discussions about a potential Somatus IPO remain speculative at this time. Factors that could influence the company's decision to go public in the future may include market conditions, the company's financial performance, and its long-term strategic goals.
Investors interested in the healthcare sector and innovative medical services companies may want to keep an eye on Somatus' developments. However, as with any potential investment opportunity, it's crucial to conduct thorough research and consider various factors before making any financial decisions.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Somatus's IPO prospects remain uncertain, investors interested in the healthcare technology sector don't have to wait on the sidelines. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides opportunities to invest in potential industry leaders like Somatus, with lower minimum investments than traditional private equity channels. This allows you to diversify your portfolio and potentially benefit from the growth of innovative healthcare companies as they revolutionize patient care and outcomes.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
